Strides Pharma stock rises 4.5% after Sandoz acquisition
after close1 source ↓written by the desknot a recommendation
- share price surged
- 4.5%
- following the acquisition
- ₹916
- since its low
- 610% return
Strides Pharma Science's share price surged 4.5% to ₹916 following the acquisition of multiple generic brands from Sandoz, aimed at enhancing its presence in the Africa market. This acquisition covers key regions like Ghana and Nigeria, focusing on therapeutic segments such as anti-infectives and cardiovascular. The stock has delivered a remarkable 610% return since its low of ₹129.
Not investment advice. For informational purposes only.